NZ720609B2 - Production method for 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine - Google Patents
Production method for 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine Download PDFInfo
- Publication number
- NZ720609B2 NZ720609B2 NZ720609A NZ72060914A NZ720609B2 NZ 720609 B2 NZ720609 B2 NZ 720609B2 NZ 720609 A NZ720609 A NZ 720609A NZ 72060914 A NZ72060914 A NZ 72060914A NZ 720609 B2 NZ720609 B2 NZ 720609B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- group
- hydrogen
- compound
- reaction
- chloro
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 18
- 239000002243 precursor Substances 0.000 title description 3
- 125000001309 chloro group Chemical group Cl* 0.000 abstract description 77
- 125000001246 bromo group Chemical group Br* 0.000 abstract description 51
- 125000002346 iodo group Chemical group I* 0.000 abstract description 38
- 238000000034 method Methods 0.000 abstract description 27
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract description 26
- 150000002993 phenylalanine derivatives Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 description 104
- 239000001257 hydrogen Substances 0.000 description 104
- 150000001875 compounds Chemical class 0.000 description 102
- 238000006243 chemical reaction Methods 0.000 description 83
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 73
- 125000004432 carbon atom Chemical group C* 0.000 description 65
- 239000002904 solvent Substances 0.000 description 60
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 59
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 51
- 125000000217 alkyl group Chemical group 0.000 description 48
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 46
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- -1 F-labeled BPA Chemical class 0.000 description 44
- 150000002431 hydrogen Chemical class 0.000 description 44
- 239000003153 chemical reaction reagent Substances 0.000 description 43
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 38
- 125000003277 amino group Chemical group 0.000 description 38
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 35
- 239000003054 catalyst Substances 0.000 description 29
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 28
- 125000006239 protecting group Chemical group 0.000 description 28
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 27
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 27
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 26
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 24
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 24
- 125000004122 cyclic group Chemical group 0.000 description 22
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 125000000623 heterocyclic group Chemical group 0.000 description 15
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 15
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 15
- 239000011135 tin Substances 0.000 description 15
- 125000001153 fluoro group Chemical group F* 0.000 description 14
- 239000003446 ligand Substances 0.000 description 14
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 13
- 150000002148 esters Chemical class 0.000 description 13
- 239000012046 mixed solvent Substances 0.000 description 13
- 229910000027 potassium carbonate Inorganic materials 0.000 description 13
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 13
- XWSGEVNYFYKXCP-UHFFFAOYSA-N 2-[carboxymethyl(methyl)amino]acetic acid Chemical compound OC(=O)CN(C)CC(O)=O XWSGEVNYFYKXCP-UHFFFAOYSA-N 0.000 description 12
- 238000006161 Suzuki-Miyaura coupling reaction Methods 0.000 description 12
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 12
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 12
- 229910052763 palladium Inorganic materials 0.000 description 12
- 229910000029 sodium carbonate Inorganic materials 0.000 description 12
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 12
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 11
- 239000004327 boric acid Substances 0.000 description 11
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 10
- 125000005843 halogen group Chemical group 0.000 description 10
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 10
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000012954 diazonium Substances 0.000 description 9
- 229910052731 fluorine Inorganic materials 0.000 description 9
- 238000002600 positron emission tomography Methods 0.000 description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 239000001632 sodium acetate Substances 0.000 description 9
- 235000017281 sodium acetate Nutrition 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 229910052736 halogen Inorganic materials 0.000 description 8
- 150000002367 halogens Chemical group 0.000 description 8
- 235000011056 potassium acetate Nutrition 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229910052796 boron Inorganic materials 0.000 description 7
- OKTJSMMVPCPJKN-BJUDXGSMSA-N carbon-11 Chemical group [11C] OKTJSMMVPCPJKN-BJUDXGSMSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 6
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- 230000002083 iodinating effect Effects 0.000 description 5
- 235000009518 sodium iodide Nutrition 0.000 description 5
- 235000010288 sodium nitrite Nutrition 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000001308 synthesis method Methods 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- BLOBPFFXHQZDGL-UHFFFAOYSA-N 2-(benzhydrylideneamino)acetic acid Chemical compound C=1C=CC=CC=1C(=NCC(=O)O)C1=CC=CC=C1 BLOBPFFXHQZDGL-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 4
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 description 4
- LRIUKPUCKCECPT-UHFFFAOYSA-N [hydroxy(phenyl)-$l^{3}-iodanyl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OI(O)C1=CC=CC=C1 LRIUKPUCKCECPT-UHFFFAOYSA-N 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 4
- 238000006193 diazotization reaction Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000002140 halogenating effect Effects 0.000 description 4
- APNSGVMLAYLYCT-UHFFFAOYSA-N isobutyl nitrite Chemical compound CC(C)CON=O APNSGVMLAYLYCT-UHFFFAOYSA-N 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical group OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 239000004304 potassium nitrite Substances 0.000 description 4
- 235000010289 potassium nitrite Nutrition 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 150000003606 tin compounds Chemical class 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- LFLVWJRUOWNNAC-UHFFFAOYSA-N dicyclohexyl-[2-phenyl-1,3,5-tri(propan-2-yl)cyclohexa-2,4-dien-1-yl]phosphane Chemical group C1CCCCC1P(C1CCCCC1)C1(C(C)C)CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1 LFLVWJRUOWNNAC-UHFFFAOYSA-N 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000003682 fluorination reaction Methods 0.000 description 3
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- MGFYSGNNHQQTJW-UHFFFAOYSA-N iodonium Chemical compound [IH2+] MGFYSGNNHQQTJW-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 239000011698 potassium fluoride Substances 0.000 description 3
- 235000003270 potassium fluoride Nutrition 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 3
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 3
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 3
- NFIVJOSXJDORSP-QMMMGPOBSA-N (2s)-2-amino-3-(4-boronophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(B(O)O)C=C1 NFIVJOSXJDORSP-QMMMGPOBSA-N 0.000 description 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
- UEWQIQAATQLBJT-UHFFFAOYSA-N 1-bromo-4-(iodomethyl)benzene Chemical compound BrC1=CC=C(CI)C=C1 UEWQIQAATQLBJT-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000005520 diaryliodonium group Chemical group 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- FFHWGQQFANVOHV-UHFFFAOYSA-N dimethyldioxirane Chemical compound CC1(C)OO1 FFHWGQQFANVOHV-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 2
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000004654 triazenes Chemical class 0.000 description 2
- PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 2
- LYRCQNDYYRPFMF-UHFFFAOYSA-N trimethyltin Chemical compound C[Sn](C)C LYRCQNDYYRPFMF-UHFFFAOYSA-N 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- HHBCEKAWSILOOP-UHFFFAOYSA-N 1,3-dibromo-1,3,5-triazinane-2,4,6-trione Chemical compound BrN1C(=O)NC(=O)N(Br)C1=O HHBCEKAWSILOOP-UHFFFAOYSA-N 0.000 description 1
- HYNPRDPHTXQIGZ-UHFFFAOYSA-N 2-(benzhydrylideneamino)acetic acid Chemical compound C1(=CC=CC=C1)C(=NCC(=O)O)C1=CC=CC=C1.C1(=CC=CC=C1)C(=NCC(=O)O)C1=CC=CC=C1 HYNPRDPHTXQIGZ-UHFFFAOYSA-N 0.000 description 1
- QZBNRNVNTZNZIP-UHFFFAOYSA-N 2-[(4-chlorophenyl)methylideneamino]acetic acid Chemical compound OC(=O)CN=CC1=CC=C(Cl)C=C1 QZBNRNVNTZNZIP-UHFFFAOYSA-N 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- ATEBGNALLCMSGS-UHFFFAOYSA-N 2-chloro-1,1-difluoroethane Chemical compound FC(F)CCl ATEBGNALLCMSGS-UHFFFAOYSA-N 0.000 description 1
- PJJLJGALGZFRKQ-GEORNKLJSA-N 4-[(r)-1-anthracen-9-ylbut-3-en-2-yloxy-[(2s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]methyl]quinolin-1-ium;bromide Chemical compound [Br-].C1=CC=C2C([C@H]([C@H]3N4CCC(C(C4)C=C)C3)OC(CC=3C4=CC=CC=C4C=C4C=CC=CC4=3)C=C)=CC=[NH+]C2=C1 PJJLJGALGZFRKQ-GEORNKLJSA-N 0.000 description 1
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- HTFCQXOJVPWKMJ-UHFFFAOYSA-N BrC(C(C=C1)=CC=C1Br)I Chemical compound BrC(C(C=C1)=CC=C1Br)I HTFCQXOJVPWKMJ-UHFFFAOYSA-N 0.000 description 1
- BAMJSRGXYFVWQE-UHFFFAOYSA-N CC(C(OCC1=CC=CC=C1)=O)(C(C=CC(Br)=C1)=C1I)N Chemical compound CC(C(OCC1=CC=CC=C1)=O)(C(C=CC(Br)=C1)=C1I)N BAMJSRGXYFVWQE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 101100208721 Mus musculus Usp5 gene Proteins 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YGPZYYDTPXVBRA-RTDBHSBRSA-N [(2r,3s,4r,5r,6s)-2-[[(2r,3r,4r,5s,6r)-3-[[(3r)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-4-[(3r)-3-tetradecanoyloxytetradecanoyl]oxyoxan-2-yl]oxymethyl]-3,6-dihydroxy-5-[[(3r)-3-hydroxytetradecanoyl]amino]oxan-4-yl] (3r)-3-hydr Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](O)O1 YGPZYYDTPXVBRA-RTDBHSBRSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KFNIDRLZPBRDNJ-UHFFFAOYSA-N benzyl 2-(benzhydrylideneamino)acetate Chemical compound C=1C=CC=CC=1COC(=O)CN=C(C=1C=CC=CC=1)C1=CC=CC=C1 KFNIDRLZPBRDNJ-UHFFFAOYSA-N 0.000 description 1
- XCTMSCBHFJLFCT-UHFFFAOYSA-N benzyltin Chemical compound [Sn]CC1=CC=CC=C1 XCTMSCBHFJLFCT-UHFFFAOYSA-N 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007350 electrophilic reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001511 metal iodide Inorganic materials 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- DJYLHNATHGUBMB-UHFFFAOYSA-N n-bromo-4-methylaniline Chemical compound CC1=CC=C(NBr)C=C1 DJYLHNATHGUBMB-UHFFFAOYSA-N 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000012985 polymerization agent Substances 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
The present invention involves preparing phenylalanine derivatives, wherein the –para position of the phenylalanine side chain is substituted with a chloro, bromo, or iodo group, and the –ortho position is substituted with an excellent leaving group or a direct synthetic intermediate. These phenylalanine derivatives can be used in a method to efficiently introduce 18F- into the molecule during the later steps in a synthetic scheme. anine derivatives can be used in a method to efficiently introduce 18F- into the molecule during the later steps in a synthetic scheme.
Description
DESCRIPTION
TITLE OF THE INVENTION: PRODUCTION METHOD FOR
2-FLUOROBORONO-L-PHENYLALANINE, AND PRECURSOR OF
2-FLUOROBORONO-L-PHENYLALANINE
TECHNICAL FIELD
The present invention relates to a method for producing
2-fluoroborono-L-phenylalanine, 4-boronophenylalanine
(fluorinated BPA)(BPA:4-Boronophenylalanine), and precursors
thereof.
BACKGROUND ART
At present, attention has been paid to positron emission
tomography (PET) as a technique that is high in sensitivity to
be excellent in quantitatively determining performance and can
form images easily in light of a principle thereof. This
technique has widely been used. The half value period of PET
diagnostic reagents (tracers) used for diagnoses is short, and
the tracers are each administrated in a fine amount so that any
living body is hardly exposed to radiation based thereon.
Therefore, this inspecting method is a low invasive inspecting
method, thus is greatly advantageous to PET. Furthermore, PET
is highly sensitive even to tumors that are not easily
determined by CT (computed tomography) or MRI (magnetic
resonance imaging), and tumor tissues thereof can be evaluated
according to images.
18 18
F-labeled BPA, in which a F-fluorine atom is introduced
into BPA, which is a boronated amino acid used as a boron reagent
for BNCT (boron neutron capture therapy), was developed as a
molecular probe for PET by Ishiwata in 1991 (Non-Patent Document
1). Thereafter, a PET inspection with the use of F-labeled
BPA using the present probe has been an important technique for
supporting BNCT. In other words, in clinical and research spots,
a F-BPA PET image obtained by measuring a subject beforehand
can give data on an internal accumulation distribution of BPA,
the ratio of tumor tissues/normal tissues (the T/N ratio) and
others. On the basis of these data, curative effects of BNCT
can be beforehand assumed and then a research or therapeutic
plan can be drawn up.
In Ishiwata’s synthesis method, BPA is directly
18 18 +
fluorinated to prepare F-labeled BPA, and F is used as an
electrophilic reagent. From deuterium (D) and neon (Ne)
accelerated by a cyclotron, F gas is prepared, and then passed
through a column filled with sodium acetate to convert the gas
-18 +
to CH COO F . Thereafter, a solution of BPA in trifluoroacetic
acid is bubbled by the introduction of this conversion-obtained
compound into the solution. In this way, the synthesis of the
target F-labeled BPA is attained.
As another method for synthesizing F-labeled BPA,
Vahatalo et al. suggest a method in which such a conventional
method is partially improved (Non-Paten Document 2). This
method is a method of using H F, which can be obtained in a
larger quantity, to attain the synthesis via CH F as an
18 18
intermediate of F . By causing CH I to react with H F, which
is obtained through the radiation of protons to H O [through
18 18 18
O(p,n) F reaction], CH F is once synthesized. The resultant
compound CH F is discharged to disassociate its C-F bonds to
18 18
prepare F . This compound is used to synthesize F-labeled
BPA, equivalently to Ishiwata’s synthesis method.
PRIOR ART DOCUMENTS
NON-PATENT DOCUMENTS
Non-Patent Document 1: Appl. Radiat. Isot., 42, 325, 1991
Non-Patent Document 2: J. Label. Compd. Radiopharm., 45,
697, 2002
SUMMARY OF THE INVENTION
PROBLEMS TO BE SOLVED BY THE INVENTION
However, the F-labeled BPA obtained by the conventional
synthesis method according to Ishiwata et al. is low in specific
radioactivity and further extremely small in yield. Even by the
improved method, the yield is still small although the specific
radioactivity of the resultant F-labeled BPA species is heightened.
One of the objectives of the present invention is to provide a
novel BPA derivative that can be an intermediate for synthesizing F-
labeled BPA.
Another objective of the present invention is to provide a method
for producing such a novel BPA derivative, and a method for producing
fluorinated BPA, including F-labeled BPA, using this derivative.
MEANS FOR SOLVING THE PROBLEMS
In order to solve the above-mentioned problems, the inventors have
made eager investigations to find out a novel method for synthesizing
fluorinated BPA. Thus, the present invention has been achieved.
[0010a]
In one aspect there is provided a compound represented by the
following formula:
[Formula 1]
wherein:
R represents a bromo group, an iodo group, a chloro group, a
nitro group, or an amino group;
2 6 7 8 + 13 14- + 13
R represents Sn(R ) , N=N-NR R , I R , (R )I R , or B(OH)
optionally esterified with pinacol, 2,2-dimethyl-1,3-propanediol, N-
methyldiethanolamine, N-methyliminodiacetic acid, 1,1,1-
trishydroxymethylethane, or catechol;
R represents an alkyl group having 1 to 7 carbon atoms or a
benzyl group;
R and R are the same or different, each representing hydrogen,
an alkyl group having 1 to 7 carbon atoms, a halogen-substituted alkyl
group having 1 to 7 carbon atoms, or a phenyl group optionally
substituted with C alkyl or C alkoxy, or else R and R are
1-6 1-6
combined together with N to form a 3- to 7-membered cyclic structure;
R represents a C -alkyl-substituted phenyl group, a C -alkoxy-
1-6 1-6
substituted phenyl group, or a phenyl group, or else represents a 5-
to 7-membered heterocyclic group having one or more of N, S, and O
atoms;
R represents halogen, a tetrafluoroborate group, a nitrate
group, a triflate group, a sulfonyloxy group, a toluenesulfonyloxy
group, or a perchlorate group;
R represents hydrogen, an ethyl group, a tert-butyl group, or a
benzyl group; and
R represents hydrogen, and R represents hydrogen, a
benzyloxycarbonyl group, or a tert-butoxycarbonyl group, or R and R
independently represents a benzyloxycarbonyl group, or a tert-
butoxycarbonyl group, or else NR R are combined together to form
C H (C H )C=N.
6 5 6 5
[0010b]
In another aspect there is provided a method for producing a
compound represented by the following formula:
[Formula 2]
wherein:
X represents F or F;
1
R represents hydrogen or a protecting group PG for a carboxyl
group;
40 50
R or R independently represents hydrogen or a protecting group
2 40 50
PG for an amino group, or else NR R are combined together to form
C H (C H )C=N; and
6 5 6 5
16
R and R are combined together with B (boron atom) to form a
ring serving as a protecting group for B;
comprising the step of reacting a compound represented by the
following formula:
[Formula 3]
wherein
R represents a bromo group, an iodo group, or a chloro group;
2 6 7 8 + 13 14- + 13
R represents Sn(R ) , N=N-NR R , I R , (R )I R , or B(OH)
optionally esterified with pinacol, 2,2-dimethyl-1,3-propanediol, N-
methyldiethanolamine, N-methyliminodiacetic acid, 1,1,1-
trishydroxymethylethane, or catechol;
R represents an alkyl group having 1 to 7 carbon atoms or a
benzyl group;
R and R are the same or different, each representing hydrogen,
an alkyl group having 1 to 7 carbon atoms, a halogen-substituted alkyl
group having 1 to 7 carbon atoms, or a phenyl group optionally
substituted with C alkyl or C alkoxy, or else R and R are combined
1-6 1-6
together with N to form a 3- to 7-membered cyclic structure;
R represents a C -alkyl-substituted phenyl group, a C -alkoxy-
1-6 1-6
substituted phenyl group, or a phenyl group, or else represents a 5-
to 7-membered heterocyclic group having one or more of N, S, and O
atoms;
R represents halogen, a tetrafluoroborate group, a nitrate
group, a triflate group, a sulfonyloxy group, a toluenesulfonyloxy
group, or a perchlorate group;
R represents hydrogen, an ethyl group, a tert-butyl group, or a
benzyl group;
R represents hydrogen and R represents hydrogen, a
benzyloxycarbonyl group, or a tert-butoxycarbonyl group, or R and R
independently represents a benzyloxycarbonyl group, or a tert-
butoxycarbonyl group, or else NR R are combined together to form
C H (C H )C=N;
6 5 6 5
1
R represents hydrogen or a protecting group PG for a carboxyl
group; and
40 50
R and R independently represents hydrogen or a protecting group
PG ;
wherein said reacting comprises reacting said compound of Formula
3 in presence of hydrogen fluoride in a solvent to obtain a
fluorinated compound and then microwave radiating the resulting
fluorinated compound in the presence of a pinacol boronation reagent,
a palladium catalyst, and a phosphorus-based ligand to form the
compound of Formula 2.
Accordingly, the present invention relates to a compound
represented by the following formula:
AH26(28495578_1):RTK
[Formula 1]
where R represents a bromo group, an iodo group, a chloro group,
a nitro group, or an amino group; R represents a halogen group,
6 7 8 9 10 11
a nitro group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid (B(OH) )
or a boric ester selected from the group consisting of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, a halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure); R represents hydrogen,
an ethyl group, a tert-butyl group, or a benzyl group; R or
R independently represents hydrogen, a benzyloxycarbonyl
group, or a tert-butoxycarbonyl group, or else NR R are
combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; R is a
chloro group, a bromo group, or a nitro group; and one of R
and R is hydrogen,
3 2 1
) case in which R is hydrogen; R is a bromo group; R is a
chloro group; and one of R and R is hydrogen,
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
In one embodiment, in the above-mentioned compound, R
represents a bromo group, an iodo group, a chloro group, a nitro
group, or an amino group; R represents a halogen group, a nitro
6 7 8 9 10 11
group, an amino group, Sn(R ), N=N-NR R, OSO R, NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid (B(OH) )
or a boric ester selected from the group consisting of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, a halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure) (here, at least one of R
and R necessarily is a bromo group, an iodo group, or a chloro
group); R represents hydrogen, an ethyl group, a tert-butyl
group, or a benzyl group; R or R independently represents a
hydrogen, benzyloxycarbonyl group, or a tert-butoxycarbonyl
group, or else NR R are combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; and R
is a chloro group, a bromo group, or a nitro group,
3 2 1
) case in which R is hydrogen; R is a bromo group; R is a
chloro group; and one of R and R is hydrogen,
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
In one embodiment, in the above-mentioned compound, R
represents a bromo group, an iodo group, a chloro group, a nitro
group, or an amino group; R represents a halogen group, a nitro
6 7 8 9 10 11
group, an amino group, Sn(R ), N=N-NR R, OSO R, NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or a boric acid (B(OH) )
or a boric ester selected from the group consisting of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, a halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure) (here, at least one of R
and R necessarily is a bromo group, an iodo group, or a chloro
group); R represents hydrogen, an ethyl group, a tert-butyl
group, or a benzyl group; R or R independently represents
hydrogen, a benzyloxycarbonyl group, or a tert-butoxycarbonyl
group, or else NR R are combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; and R
is a chloro group, a bromo group, or a nitro group,
3 2 1
) case in which R is hydrogen; R is a bromo group; and R is
a chloro group,
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
The present invention also relates to a method for
producing a compound represented by the following formula:
[Formula 2]
18 30
(where X represents F or F; R represents hydrogen or a
1 40 50
protecting group PG for a carboxyl group; R or R
independently represents hydrogen or a protecting group PG for
40 50
an amino group, or else NR R are combined together to form
16
C H (C H )C=N; and R and R are combined together with B (boron
6 5 6 5
atom) to form a ring serving as a protecting group for B),
comprising the step of using a compound represented by the
following formula:
[Formula 3]
where R represents a bromo group, an iodo group, a chloro group,
a nitro group, or an amino group; R represents a halogen group,
6 7 8 9 10 11
a nitro group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid or a boric
ester (where R represents an alkyl group having 1 to 7 carbon
atoms or a benzyl group; R and R are the same or different,
each representing hydrogen, an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
atoms, or an optionally substituted phenyl group, or else R
and R are combined together with N to form a 3- to 7-membered
cyclic structure; R represents an alkyl group having 1 to 7
carbon atoms, a halogen-substituted alkyl group having 1 to 7
carbon atoms, or an optionally substituted phenyl group; R
and R are the same or different, each representing an alkyl
group having 1 to 7 carbon atoms, a halogen-substituted alkyl
group having 1 to 7 carbon atoms, or an optionally substituted
11
phenyl group, or else R and R are combined together with N
40
to form a 3- to 7-membered cyclic structure); and R , R , and
R have the same meaning as described above.
The present invention also relates to a method for
producing F-labeled BPA, comprising the step of using a
compound represented by the following formula:
[Formula 4]
18 30 40 50
(where X represents F or F; R , R , and R have the same meaning
16
as described above; and R and R are combined together with
B (boron atom) to form a ring serving as a protecting group for
EFFECT OF THE INVENTION
The novel compound and the production method of the
present invention are favorably usable, particularly, for
producing F-labeled BPA.
MODE FOR CARRYING OUT THE INVENTION
The existing methods for synthesizing F-labeled BPA are
methods for fluorinating BPA directly, and are attained, in
particular, by conducting an electrophilic reaction by use of
F as an electrophilic reagent. The inventors have paid
attention to the following: in the step of preparing F gas
+ 18
in a cyclotron, the step of using F from the resultant F gas,
and some other steps in such an existing synthesis route,
problems are caused, respectively; and further, F-labeled BPA
obtained finally has a lowered specific radioactivity by the
generation of a reaction product from intermingled F
molecules or by some other causes, and the quantity of
F-labeled BPA usable for PET diagnosis according to a single
synthesis is a quantity for only several persons. A novel
method of the present invention for synthesizing F-labeled
BPA is entirely different from the conventional methods, and
is a synthesis method in which F anions are usable. This
method imposes little load on the apparatus, and makes it
possible to synthesize F-labeled BPA to give a yield larger
than the respective yields according to the conventional
synthesis methods.
In the present invention, first, a novel method for
producing fluorinated BPA, in particular, a method for
producing F-labeled BPA, is found out. Further, in such novel
method for producing F-labeled BPA, several novel
intermediate compounds are obtained. By this novel method for
18 18
producing F-labeled BPA, F-labeled BPA can be obtained at
a high yield in a simple and convenient manner.
In the present invention, here, the wording “fluorinated
BPA” denotes:
[Formula 5]
or is used as a term including the following F-labeled BPA.
Here, the F-labeled BPA denotes:
[Formula 6]
In the present invention, a novel intermediate compound that
finally leads to synthesis of these fluorinated BPA compounds
is provided.
In the present invention, the novel intermediate compound
has the same meaning as a compound represented by the following
formula:
[Formula 7]
where R represents a bromo group, an iodo group, a chloro group,
a nitro group, or an amino group; R represents a halogen group,
6 7 8 9 10 11
a nitro group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid (B(OH) ),
or a boric ester selected from the group consisting of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, a halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure); R represents hydrogen,
an ethyl group, a tert-butyl group, or a benzyl group; R or
R independently represents hydrogen, a benzyloxycarbonyl
group, or a tert-butoxycarbonyl group, or else NR R are
combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; R is a
chloro group, a bromo group, or a nitro group; and one of R
and R is hydrogen,
3 2 1
) case in which R is hydrogen; R is a bromo group; R is a
chloro group; and one of R and R is hydrogen,
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
Though not particularly limited, it is preferable further
that R represents a bromo group, an iodo group, a chloro group,
a nitro group, or an amino group; R represents a halogen group,
6 7 8 9 10 11
a nitro group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid (B(OH) )
or a boric ester selected from the group consisting of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure) (here, at least one of R
and R necessarily is a bromo group, an iodo group, or a chloro
group); R represents hydrogen, an ethyl group, a tert-butyl
group, or a benzyl group; R or R independently represents
hydrogen, a benzyloxycarbonyl group, or a tert-butoxycarbonyl
group, or else NR R are combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; and R
is a chloro group, a bromo group, or a nitro group,
3 2 1
) case in which R is hydrogen; R is a bromo group; R is a
chloro group; and one of R and R is hydrogen,
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
Further, in another embodiment, it is preferable that R
represents a bromo group, an iodo group, a chloro group, a nitro
group, or an amino group; R represents a halogen group, a nitro
6 7 8 9 10 11
group, an amino group, Sn(R ), N=N-NR R, OSO R, NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid (B(OH) )
or a boric ester selected from the group consisting of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, a halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure) (here, at least one of R
and R necessarily is a bromo group, an iodo group, or a chloro
group); R represents hydrogen, an ethyl group, a tert-butyl
group, or a benzyl group; R or R independently represents
hydrogen, a benzyloxycarbonyl group, or a tert-butoxycarbonyl
group, or else NR R are combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; and R
is a chloro group, a bromo group, or a nitro group,
3 2 1
) case in which R is hydrogen; R is a bromo group; and R is
a chloro group,
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
Further, in another embodiment, it is preferable that R
represents a bromo group, an iodo group, a chloro group, a nitro
group, or an amino group; R represents a halogen group, a nitro
6 7 8 9 10 11 + 13
group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R , I R ,
14- + 13
(R )I R , or boric acid or a boric ester selected from the group
consisting of pinacol, 2,2-dimethyl-1,3-propanediol,
N-methyldiethanolamine, 1,8-diaminonaphthalene,
N-methyliminodiacetic acid, 1,1,1-trishydroxymethylethane,
6 7 8
and catechol (where R represents methyl or n-butyl; R and R
are the same or different, each representing hydrogen, methyl,
ethyl, propyl, butyl, heptyl, trifluoromethyl, or an optionally
substituted phenyl group, or else R and R are combined together
with N to form aziridine, azetidine, pyrrolidine, or
piperidine; R represents methyl, ethyl, propyl, butyl, heptyl,
trifluoromethyl, or an optionally substituted phenyl group; R
and R are the same or different, each representing methyl,
ethyl, propyl, butyl, heptyl, trifluoromethyl, or an optionally
11
substituted phenyl group, or else R and R are combined
together with N to form aziridine, azetidine, pyrrolidine, or
piperidine; R represents a C -alkyl-substituted phenyl group,
a C -alkoxy-substituted phenyl group, or a phenyl group, or
else represents a 5- to 7-membered heterocyclic group having
one or more of N, S, and O atoms; and R represents halogen,
a tetrafluoroborate group, a nitrate group, a triflate group,
a sulfonyloxy group, a toluenesulfonyloxy group, or a
perchlorate group) (here, at least one of R and R necessarily
is a bromo group, an iodo group, or a chloro group); R represents
hydrogen, an ethyl group, a tert-butyl group, or a benzyl group;
R represents hydrogen; R represents hydrogen, a
benzyloxycarbonyl group, or a tert-butoxycarbonyl group, or
else NR R are combined together to form C H (C H )C=N;
6 5 6 5
(except that excluded herefrom are the following cases:
3 4 5 2
1) case in which all of R , R , and R are hydrogen, and R is
a chloro group,
3 4 5 2
2) case in which all of R , R , and R are hydrogen; R is a bromo
group; and R is a bromo group, a chloro group, a nitro group,
or an amino group,
3 4 5 2
3) case in which all of R , R , and R are hydrogen; R is an
iodo group; and R is a chloro group or a nitro group,
3 2 1
4) case in which R is hydrogen; R is a chloro group; and R
is a chloro group, a bromo group, or a nitro group (here, one
of R and R can be hydrogen; however, a case in which neither
of R nor R is hydrogen is also included),
3 2 1
) case in which R is hydrogen; R is a bromo group; and R is
a chloro group (here, one of R and R can be hydrogen; however,
a case in which neither of R nor R is hydrogen is also included),
4 5 2
6) case in which R and R are hydrogen; R is a chloro group;
and R is a nitro group,
7) case in which NR R are combined together to form C H (C H )C=N,
6 5 6 5
and R is a fluoro group, and
8) case in which R is a chloro group; R is a fluoro group;
4 5 3
R and R are hydrogen; and R is an ethyl group).
The novel intermediate compound of the present invention
is particularly preferably the compound described above,
wherein R represents a bromo group, an iodo group, or a chloro
2 6 7 8 9 10 11 + 13
group, and R represents Sn(R ) , N=N-NR R , OSO R , NR R , I R ,
14- + 13
(R )I R, or boric acid or one of pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol.
The novel intermediate compound of the present invention
is particularly preferably the compound described above,
wherein R is an iodo group or a bromo group.
The novel compound of the present invention is
particularly preferably provided, for example, as an
intermediate compound for preparing PET diagnostic
pharmaceuticals, although not limited thereto.
In the present invention, a compound represented by the
following formula:
[Formula 9]
18 30
(where X represents F or F; R represents hydrogen or a
1 40 50
protecting group PG for a carboxyl group; and R or R
independently represents hydrogen or a protecting group PG for
40 50
an amino group, or else NR R are combined together to form
16
C H (C H )C=N; and R and R are combined together with B (boron
6 5 6 5
atom) to form a ring serving as a protecting group for B) can
be produced by using a compound represented by the following
formula:
[Formula 8]
where R represents a bromo group, an iodo group, a chloro group,
a nitro group, or an amino group; R represents a halogen group,
6 7 8 9 10 11
a nitro group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, or boric acid or a boric
ester (where R represents an alkyl group having 1 to 7 carbon
atoms or a benzyl group; R and R are the same or different,
each representing hydrogen, an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
atoms, or an optionally substituted phenyl group, or else R
and R are combined together with N to form a 3- to 7-membered
cyclic structure; R represents an alkyl group having 1 to 7
carbon atoms, a halogen-substituted alkyl group having 1 to 7
carbon atoms, or an optionally substituted phenyl group; R
and R are the same or different, each representing an alkyl
group having 1 to 7 carbon atoms, a halogen-substituted alkyl
group having 1 to 7 carbon atoms, or an optionally substituted
11
phenyl group, or else R and R are combined together with N
to form a 3- to 7-membered cyclic structure) (it is preferable
that at least one of R and R necessarily is a bromo group,
40 50
an iodo group, or a chloro group); and R , R , and R have the
same meaning as described above. Thus obtained compound can
be used to finally produce fluorinated BPA, in particular,
F-labeled BPA.
In the present invention, F-labeled BPA can be produced
by using a compound represented by the following formula:
[Formula 10]
where R represents a bromo group, an iodo group, a chloro group,
a nitro group, or an amino group; R represents a halogen group,
6 7 8 9 10 11
a nitro group, an amino group, Sn(R ) , N=N-NR R , OSO R , NR R ,
substituted or unsubstituted phenyl iodo, a substituted or
unsubstituted heterocyclic iodo group, boric acid, or a boric
ester (particularly preferably pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, or catechol) (where R
represents an alkyl group having 1 to 7 carbon atoms or a benzyl
group; R and R are the same or different, each representing
hydrogen, an alkyl group having 1 to 7 carbon atoms, a
halogen-substituted alkyl group having 1 to 7 carbon atoms, or
an optionally substituted phenyl group, or else R and R are
combined together with N to form a 3- to 7-membered cyclic
structure; R represents an alkyl group having 1 to 7 carbon
atoms, a halogen-substituted alkyl group having 1 to 7 carbon
11
atoms, or an optionally substituted phenyl group; R and R
are the same or different, each representing an alkyl group
having 1 to 7 carbon atoms, a halogen-substituted alkyl group
having 1 to 7 carbon atoms, or an optionally substituted phenyl
11
group, or else R and R are combined together with N to form
a 3- to 7-membered cyclic structure) (here, at least one of R
and R necessarily is a bromo group, an iodo group, or a chloro
1
group); R represents hydrogen or a protecting group PG for
40 50
a carboxyl group; and R or R independently represents
hydrogen or a protecting group PG for an amino group, or else
40 50
NR R are combined together to form C H (C H )C=N.
6 5 6 5
In the present specification, the wording “are combined
together with N to form a cyclic structure having 3 to 7 atoms”
denotes a saturated or unsaturated ring having carbon and
nitrogen. Although not limited, examples thereof include
piperidine, piperazine, pyrrolidine, pyridine, pyrimidine,
pyrazine, pyrazole, and imidazole.
In the present specification, the wording heterocyclic
group denotes a group having a saturated or unsaturated cyclic
structure having carbon and an atom other than carbon and, in
particular, thienyl group, furanyl group, pyridinyl group,
piperidinyl group, piperazinyl group, and the like are
preferable.
1
R represents hydrogen or a protecting group PG for a
carboxylic acid. Here, PG is not particularly limited and
denotes any protecting group known by those skilled in the art
for a carboxylic acid. Examples thereof include protecting
groups described in Greene Wuts, “Protective Groups in Organic
Synthesis”, 3rd edition (a company, Wiley-Interscience in USA).
Typically, the group concerned can be converted into an ester
type to be protected, using ester condensation conditions or
alkylation conditions. PG is, for example, an alkyl group
having 1 to 7 carbon atoms or an aromatic group such as a benzyl
group. Specific examples thereof include alkyl groups such as
a methyl group, an ethyl group, an n-propyl group, an iso-propyl
group, an n-butyl group, an iso-butyl group, a sec-butyl group,
a tert-butyl group, and an n-pentyl group, and aromatic groups
such as a benzyl, p-methoxybenzyl, and p-nitrobenzyl groups.
PG is in particular preferably a tert-butyl or a benzyl group,
which is not easily affected by racemization when de-protection
3
is carried out. Also, R may have the same meaning as R .
40 50
R or R independently represents hydrogen or a
protecting group PG for an amino group. The protecting group
for an amino acid may be any protecting group known by those
skilled in the art. Examples thereof include protecting groups
described in Greene Wuts, “Protective Groups in Organic
Synthesis”, 3rd edition (the company, Wiley-Interscience in
USA). Preferred examples thereof include a benzyloxycarbonyl
group, an acetyl group, a trifluoroethylcarboxy group, a
tert-butyloxycarbonyl group, a fluorenylmethyloxycarbonyl
group, a trichloroethoxycarbonyl group, a trifluoroacetyl
group, an allyloxycarbonyl group, a benzyl group, a
propargyloxycarbonyl group, a benzoyl group, a phthaloyl group,
a toluenesulfonyl group, and a nitrobenzenesulfonyl group,
although the protecting group is not limited thereto. Of these
examples, a benzyloxycarbonyl group and a
tert-butyloxycarbonyl group are preferred, which can be
subjected to de-protection in a short period of time. R or
50 4 5
R may have the same meaning as R and R , respectively.
16
In the present specification, when R and R are combined
together with B (boron atom) to form a ring as a protecting group
16
for B, R and R are preferably a group that forms a saturated
or unsaturated 3- to 10-membered ring which may be substituted.
Examples of the structure of the ring herein also include
spiro-rings and condensed rings. Examples of the group that
can form the ring include pinacol,
2,2-dimethyl-1,3-propanediol, N-methyldiethanolamine,
1,8-diaminonaphthalene, N-methyliminodiacetic acid,
1,1,1-trishydroxymethylethane, and catechol, although the
group is not limited. In particular, pinacol is preferred.
In the present specification, the alkyl group having 1
to 7 carbon atoms is in particular preferably a methyl group,
an ethyl group, an n-propyl group, an iso-propyl group, an
n-butyl group, an iso-butyl group, a sec-butyl group, a
tert-butyl group, or an n-pentyl group. The
halogen-substituted alkyl group denotes an alkyl group having
1 to 7 carbon atoms wherein an arbitrary number of the hydrogen
atoms thereof are substituted with one or more halogens. The
halogen-substituted alkyl group is preferably a
trifluoromethyl group, although the group is not limited. The
substituted phenyl group denotes a phenyl group, or a phenyl
group having, at one to three positions of the phenyl group,
one or more substituents independently of each other. The
substituted 3- to 10-membered ring denotes a 3- to 10-membered
ring, or a 3- to 10-membered ring having, at one to three
positions of the 3- to 10-membered ring, one or more
substituents independently of each other. The substituted
heterocyclic group denotes a heterocycle, or a heterocyclic
group having, at one to three positions of the heterocycle, one
or more substituents independently of each other. Examples of
the substituent(s) of the phenyl group, the 3- to 10-membered
ring, or the heterocycle include a C alkyl group, a C alkoxyl
1-6 1-6
group, a hydroxyl group, an amino group, and a nitro group,
although the substituent(s) is/are not limited.
In the novel method for producing F-labeled BPA of the
present invention, for example, the following step S, step T,
step U, or step V may be exemplified, although the steps are
not limited thereto. Here, the protecting groups used in the
following reaction formulae may be appropriately changed, so
that the protecting groups are not limited to these examples.
Step S
[Formula 11]
AH26(28495578_1):RTK
Step T
[Formula 12]
Step U
AH26(28495578_1):RTK
[Formula 13]
AH26(28495578_1):RTK
[Formula 14]
Step V
AH26(28495578_1):RTK
[Formula 15]
In the reaction in each of the steps S to V, the reaction
temperature varies in accordance with the solvent, the starting
materials, the reagent(s), and others, and is appropriately
selected. Also, the reaction period varies in accordance with
the solvent, the starting materials, the reagent(s), the
reaction temperature, and others, and is appropriately
selected.
In the reaction in each of the steps, the target compound
of each step may be isolated from the reaction mixture by a
routine procedure after the end of each reaction.
The target compound is obtained, for example, by (i)
filtrating away the catalyst and other insoluble substances in
accordance with the needs, (ii) adding, to the reaction mixture,
water and a solvent immiscible in water (for example, ethyl
acetate, chloroform, or the like) to extract the target compound,
(iii) washing the organic layer with water and using a drying
agent such as anhydrous magnesium sulfate to dry the resultant
in accordance with the needs, and (iv) distilling off the
solvent. The obtained target compound may be further purified
by a known method (for example, silica gel column chromatography
or the like) in accordance with the needs. Also, the target
compound in each of the steps may be supplied to the next reaction
without being purified.
(Step S)
In other words, Step S-1 is a step of causing a compound
(401) to react with a nitrite in an acidic aqueous solution to
produce a diazonium salt, so as to produce a compound (402) which
is a halogen derivative. The compound (401) is known and is
commercially available; however, the compound (401) may be
obtained by synthesis from a commercially available compound.
The diazonium reaction reagent may be, for example,
sodium nitrite, potassium nitrite, or further an alkyl nitrite
such as isobutyl nitrite. Also, the iodinating reagent may be,
for example, sodium iodide, potassium iodide, or iodine, which
is known.
Examples of the solvent to be used include water, acetone,
acetonitrile, THF, methanol, ethanol, and mixed solvents each
composed of two or more kinds of these solvents. Among these,
acetone is preferred, since this solvent is inactive to the
diazotization reaction.
The reaction temperature is preferably from -20 C to room
temperature, more preferably from -10 C to 5 C. The reaction
period is preferably from 30 minutes to 2 hours, more preferably
from 30 minutes to 1 hour.
(Step S-2)
Step S-2 is a step of causing the compound (402) to react
with a halogenating reagent in the presence of a catalyst to
produce a compound (403).
Examples of the halogenating reagent to be used include
N-bromosuccinimide and dibromoisocyanuric acid. In the case
in which a halogenating reagent other than a bromo group is used,
examples of the halogenating reagent to be used include
1,3-diiodo-5,5’-dimethylhydantoin and N-iodosuccinimide.
Meanwhile, the catalyst to be used is a radical polymerization
agent such as a peroxide or AIBN.
The solvent to be used is not particularly limited and
may be, for example, benzene, chloroform, carbon tetrachloride.
Carbon tetrachloride is particularly preferred.
The reaction temperature is preferably from room
temperature to 120 C, more preferably from 70 C to 100 C.
The reaction period is preferably from 1 hour to 24 hours,
more preferably from 6 hours to 18 hours.
Step S-3 is a step of causing the compound (403) to react
with a phase-transfer catalyst and a modified amino acid that
are generally used in Maruoka’s reaction in the presence of a
base to produce a compound (404) newly.
The modified amino acid to be used in Maruoka’s reaction
is not limited. Preferred examples thereof include a methyl
ester of N-diphenylmethyleneglycine, an ethyl ester of
N-diphenylmethyleneglycine, a t-butyl ester of
N-diphenylmethyleneglycine N-diphenylmethyleneglycine, a
t-butyl ester of 4-chlorobenzylideneglycine, and a benzyl ester
ester of N-diphenylmethyleneglycine. Of these examples,
particularly preferred is a t-butyl ester of
N-diphenylmethyleneglycine.
The base to be used is not limited. Preferred examples
thereof include lithium hydroxide, sodium hydroxide, potassium
hydroxide, and further, triethylamine. In view of the reaction
rate, potassium hydroxide is particularly preferred.
Preferred examples of the modified amino acid to be used
in Maruoka’s reaction include
O-allyl-N-(9-anthracenylmethyl)cinchonidinium bromide, and
(S)-(+)-4,4-dibutyll-2,6-bis(3,4,5-trifluorophenyl)-4,5-dih
ydro-3H-dinaphtho[7,6,1,2-CDE]azemipium bromide.
Preferred examples of the solvent to be used include
toluene, dichloromethane, and chloroform. Toluene is
particularly preferred in view of the environment.
The reaction temperature is preferably from -20 C to 100 C,
more preferably from -4 C to room temperature.
The reaction period is preferably from 30 minutes to 24
hours, more preferably from 1 hour to 18 hours.
The obtained compound may be purified; however, the
compound may be shifted to the next step without being purified.
(Step S-4)
Step S-4 is a step of putting the compound (404) to an
acidic aqueous solution to eliminate an amino-group protector
thereof. The solvent to be used therefor may be a mixed solvent
of citric acid or oxalic acid in water and acetone, acetonitrile,
THF, DMF, or DMSO; however, a preferable example is a mixed
solvent of citric acid or oxalic acid in water and acetone,
acetonitrile, or THF in view of distilling off the solvent.
Here, the reaction temperature is preferably from room
temperature to 100 C, more preferably from room temperature to
80 C. The reaction period is preferably from 30 minutes to 24
hours, more preferably from 1 hour to 3 hours.
(Step S-5)
Step S-5 is a step of using a protecting reagent for the
compound (405) to protect an amino group thereof under basic
conditions. The protecting reagent to be used may be, for
example, benzyl chloroformate, or di-t-butyl dicarbonate,
although the reagent is not limited to the exemplified
compounds.
Preferred examples of the base to be used include lithium
hydroxide, sodium hydroxide, potassium hydroxide, sodium
carbonate, potassium carbonate, and further, triethylamine,
although the base is not limited thereto. In particular, sodium
carbonate and potassium carbonate are preferred, which are
mild.
The solvent to be used is preferably an amphipathic
solvent. In particular, examples thereof include acetone,
acetonitrile, THF, DMF, and DMSO. The solvent is preferably
acetone, acetonitrile, or THF in view of distilling off the
solvent.
The reaction temperature is preferably from -20 C to 100 C,
more preferably from -4 C to room temperature. The reaction
period is preferably from 30 minutes to 24 hours, more
preferably from 3 hours to 18 hours.
(Step S-6)
Step S-6 is a step of producing, from the compound, a
trialkyltin compound by a Suzuki-Miyaura coupling reaction.
The reaction reagent to be used is benzyltin, and the catalyst
to be used may be a palladium catalyst that is generally used
in Suzuki-Miyaura coupling reaction, examples thereof
including a palladium chloride cinnamyl complex, palladium
acetate, trisdibenzylideneacetonedipalladium, and
tetrakistriphenylphenylphosphinopalladium, although the
catalyst is not limited to these. Of these examples, preferred
is tetrakistriphenylphenylphosphinopalladium.
Examples of the base to be used include lithium hydroxide,
sodium hydroxide, potassium hydroxide, sodium carbonate,
potassium carbonate, sodium acetate, potassium acetate, and
further, triethylamine; however, sodium acetate and potassium
acetate are preferred, which are milder.
A preferred solvent to be used is, for example, toluene
or dioxane. The reaction temperature is preferably from room
temperature to 150C, more preferably from 80 C to 120 C. The
reaction period is preferably from 1 hour to 48 hours, more
preferably from 2 hours to 24 hours.
(Step S-7)
Further, Step S-7 for converting the compound (407) to
a compound (408) may be, for example, as follows, although not
limited.
The compound (407) is dissolved into a solvent, and
thereto is added an iodonium, such as Koser’s reagent, under
a nitrogen gas flow.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, trifluoroethanol, and mixed solvents each composed of
two or more kinds of these solvents. Among these,
dichloromethane is preferred.
The reaction temperature is preferably from -20 C to room
temperature, more preferably from -10 C to 5 C. The reaction
period is preferably from 30 minutes to 2 hours.
(Step S-8)
A reagent used in Step S-8 for converting the compound
(408) to a compound (409) may be, for example, hydrogen
fluoride.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, DMF, DMSO, and mixed solvents each composed of two or
more kinds of these solvents. Of these examples, preferred is
dichloromethane alone or a combination with acetonitrile, DMF,
or DMSO.
The reaction temperature is preferably from -20 C to 180 C,
more preferably from 80 C to 160 C. The reaction period is
preferably from 5 minutes to 2 hours, more preferably from 10
minutes to 1 hour.
(Step S-9)
Step S-9 is a step of using a pinacol boronation reagent
to produce a pinacol boric acid derivative from the compound
409 using a microwave radiation or the like in the presence of
a palladium catalyst and a ligand. The catalyst to be used may
be a palladium catalyst that is generally used in Suzuki-Miyaura
coupling reaction, examples thereof including a palladium
chloride cinnamyl complex, palladium acetate, and
trisdibenzylideneacetonedipalladium, although the catalyst is
not limited to these.
The microwave radiation conditions are preferably from
room temperature to 200 C, more preferably from 80 C to 180.
The reaction period is preferably from 1 minute to 60 minutes,
more preferably from 5 minutes to 30 minutes.
The ligand to be used may be a phosphorus-based ligand
that is generally used in Suzuki-Miyaura coupling reaction,
examples thereof including tricyclohexylphosphine,
2-dicyclohexylphosphino-2,4,6-triisopropylbiphenyl,
2-dicyclohexylphosphino-2,-(N,N)-dimethylaminobiphenyl,
3,5-dimethoxydicyclohexylphosphino-2,4,6-triisopropylbip
henyl, and
3,5-dimethoxyditert-butylphosphino-2,4,6-triisopropylbip
henyl, although the ligand is not limited to these.
Examples of the base to be used include lithium hydroxide,
sodium hydroxide, potassium hydroxide, sodium carbonate,
potassium carbonate, and further, triethylamine, although the
base is not limited thereto. In particular, sodium carbonate
and potassium carbonate are preferred, which are mild.
Preferred examples of the solvent to be used include
toluene, dioxane, and DMDO.
(Step T-1)
Step T-1 is a step of producing a compound 502 by
iodinating the compound 501. The method for iodination
reaction may be, for example, a method of causing a metal
perchlorate such as sodium perchlorate or sodium perchlorate
to react with iodine or a metal iodide such as sodium iodide,
or further a method of using an iodinating reagent such as
N-iodosuccinimide in a strong acid such as sulfuric acid or
trifluoromethanesulfonic acid.
(Step T-2)
Step T-2 is a step of using a protecting reagent for the
compound (502) to protect an amino group thereof under basic
conditions. The protecting reagent to be used may be, for
example, benzyl chloroformate, or di-t-butyl dicarbonate,
although the reagent is not limited to the exemplified
compounds.
Preferred examples of the base to be used include lithium
hydroxide, sodium hydroxide, potassium hydroxide, sodium
carbonate, potassium carbonate, and further, triethylamine,
although the base is not limited thereto. In particular, sodium
carbonate and potassium carbonate are preferred, which are
mild.
The solvent to be used is preferably an amphipathic
solvent. In particular, examples thereof include acetone,
acetonitrile, THF, DMF, and DMSO. The solvent is preferably
acetone, acetonitrile, or THF in view of distilling off the
solvent.
The reaction temperature is preferably from -20 C to 100 C,
more preferably from -4 C to room temperature. The reaction
period is preferably from 30 minutes to 24 hours, more
preferably from 3 hours to 18 hours.
(Step T-3)
Step T-3 is a step of using a protecting reagent for the
compound (503) to protect a carboxyl group thereof.
Examples of the solvent to be used include acetone, ethyl
acetate, chloroform, THF, dioxane, methanol, and ethanol.
Among these, methanol and ethanol are preferred, since these
solvents are inactive to the reduction reaction.
The reaction temperature is preferably from -20 C to 100 C,
more preferably from room temperature to 50 C. The reaction
period is preferably from 30 minutes to 24 hours, more
preferably from 3 to 18 hours.
(Step T-4)
Step T-4 is a step of producing a compound 505 by reducing
the compound 504 to turn the nitro group thereof into an amino
group. Examples of the reducing agent include those causing
reaction with an inorganic salt such as calcium chloride or an
acid such as hydrochloric acid in the presence of iron, zinc,
or tin, and further those reducing with a hydrogen gas in the
presence of palladium, rubidium, ruthenium, or a complex
thereof, although the reducing agent is not limited thereto.
Examples of the solvent to be used include acetone,
acetonitrile, THF, methanol, and ethanol. Among these,
methanol and ethanol are preferred, since these solvents are
inactive to the reduction reaction.
The reaction temperature is preferably from -20 C to 100 C,
more preferably from room temperature to 50C. The reaction
period is preferably from 30 minutes to 24 hours, more
preferably from 3 to 18 hours.
(Step T-5)
Step T-5 is a step of producing a halogen derivative (506)
from the compound (505) via a diazonium. The diazonium reaction
reagent may be, for example, sodium nitrite, potassium nitrite,
or further an alkyl nitrite such as isobutyl nitrite. Also,
the iodinating reagent may be, for example, sodium iodide,
potassium iodide, or iodine, which is known.
Examples of the solvent to be used include water, acetone,
acetonitrile, THF, methanol, ethanol, and mixed solvents each
composed of two or more kinds of these solvents. Among these,
acetone is preferred, since this solvent is inactive to the
diazotization reaction.
The reaction temperature is preferably from -20 C to room
temperature, more preferably from -10 C to 5 C. The reaction
period is preferably from 30 minutes to 2 hours, more preferably
from 30 minutes to 1 hour.
The halogen derivative (506) obtained in this manner is
subjected to synthesis of a compound similar to the compound
410 in the same manner as in Steps S-6 to S-9.
(Step U-1 to Step U-4)
Further, Steps U-1 to U-4 are steps similar to Steps S-2
to S-5 and are steps of preparing compounds 601, 602, 603, 604,
and 605.
(Step U-5)
Step U-5 is a step of subjecting the compound (605) to
hydrogenating reduction to produce an aniline derivative. A
catalyst to be used therefor is, for example, palladium
hydroxide or palladium carbon, although the catalyst is not
limited thereto.
Examples of the solvent to be used include acetone,
acetonitrile, THF, methanol, and ethanol. Among these,
methanol and ethanol are preferred, since these solvents are
inactive to the reduction reaction.
The reaction temperature is preferably from -20 C to 100 C,
more preferably from room temperature to 50 C. The reaction
period is preferably from 30 minutes to 24 hours, more
preferably from 3 to 18 hours.
(Step U-6)
Step U-6 is a step of producing, from the compound (606),
a triazene derivative (607) via a diazonium.
The diazonium reaction reagent to be used may be, for
example, sodium nitrite, potassium nitrite, or further an alkyl
nitrite such as isobutyl nitrite. Also, the reaction reagent
may be, for example, dimethylamine, cyclopentylamine, or
cyclohexylamine, which is known.
Examples of the solvent to be used include water, acetone,
acetonitrile, THF, methanol, ethanol, and mixed solvents each
composed of two or more kinds of these solvents. Among these,
acetone is preferred, since this solvent is inactive to the
diazotization reaction.
The reaction temperature is preferably from -20 C to room
temperature, more preferably from -10 C to 5 C. The reaction
period is preferably from 30 minutes to 2 hours, more preferably
from 30 minutes to 1 hour. Also, from the compound (607) to
(611) can be produced as well.
(Step U-7)
Step U-7 is a step of producing a halogen derivative (608)
from the compound (606) via a diazonium. The diazonium reaction
reagent may be, for example, sodium nitrite, potassium nitrite,
or further an alkyl nitrite such as isobutyl nitrite. Also,
the iodinating reagent may be, for example, sodium iodide,
potassium iodide, or iodine, which is known.
Examples of the solvent to be used include water, acetone,
acetonitrile, THF, methanol, ethanol, and mixed solvents each
composed of two or more kinds of these solvents. Among these,
acetone is preferred, since this solvent is inactive to the
diazotization reaction.
The reaction temperature is preferably from -20 C to room
temperature, more preferably from -10 C to 5 C. The reaction
period is preferably from 30 minutes to 2 hours, more preferably
from 30 minutes to 1 hour.
(Step U-8)
Step U-8 is a step of producing, from the compound (608),
a trialkyltin compound (609) by a Suzuki-Miyaura coupling
reaction. The reaction reagent to be used may be, for example,
tributyltin or trimethyltin. The catalyst to be used may be
a palladium catalyst that is generally used in Suzuki-Miyaura
coupling reaction, examples thereof including a palladium
chloride cinnamyl complex, palladium acetate,
trisdibenzylideneacetonedipalladium, and
tetrakistriphenylphenylphosphinopalladium, although the
catalyst is not limited to these. Of these examples, preferred
is tetrakistriphenylphenylphosphinopalladium.
Examples of the base to be used include lithium hydroxide,
sodium hydroxide, potassium hydroxide, sodium carbonate,
potassium carbonate, sodium acetate, potassium acetate, and
further, triethylamine; however, sodium acetate and potassium
acetate are preferred, which are milder.
A preferred solvent to be used is, for example, toluene
or dioxane. The reaction temperature is preferably from room
temperature to 150 C, more preferably from 80 C to 120 C. The
reaction period is preferably from 1 hour to 48 hours, more
preferably from 2 hours to 24 hours.
(Step U-9)
For Step U-9 for converting the compound (609) to a
compound (610), the following operation is given as an example,
although an operation therefor is not limited.
The compound (609) is dissolved into a solvent, and
thereto is then added an iodonium, such as Koser’s reagent,
under a nitrogen gas flow.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, trifluoroethanol, and mixed solvents each composed of
two or more kinds of these solvents. Among these,
dichloromethane is preferred.
The reaction temperature is preferably from -20 C to room
temperature, more preferably from -10 C to 5 C. The reaction
period is preferably from 30 minutes to 2 hours.
(Step U-10)
A reagent used in step U-10 for converting the compound
compound (610) to a compound (611) may be, for example, hydrogen
fluoride.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, DMF, DMSO, and mixed solvents each composed of two or
more kinds of these solvents. Of these examples, preferred is
dichloromethane alone or a combination with acetonitrile, DMF,
or DMSO.
The reaction temperature is preferably from -20 C to 180 C,
more preferably from 80 C to 160 C. The reaction period is
preferably from 5 minutes to 2 hours, more preferably from 10
minutes to 1 hour.
(Step U-11)
Step U-11 is a step of using a pinacol boronation reagent
to produce a pinacol boric acid derivative from the compound
611 using a microwave radiation in the presence of a palladium
catalyst and a ligand by a method similar to that of Step S-9.
(Step U-12)
Step U-12 is a step of using a butoxycarbonylation reagent
in the presence of DMAP to produce a di-Boc acid derivative from
the compound (608).
Examples of the solvent to be used include toluene,
dioxane, acetone, DMF, DMSO, and MeCN, although the solvent is
not limited. In particular, acetone and MeCN are preferred.
The reaction temperature is preferably from room
temperature to 100 C, more preferably from 30 C to 60 C.
The reaction period is preferably from 8 hours to 48 hours,
more preferably from 12 hours to 24 hours.
(Step U-13)
Step U-13 is a step of producing, from the compound (613),
a trialkyltin compound (614) by a Suzuki-Miyaura coupling
reaction. The reaction reagent to be used may be, for example,
tributyltin or trimethyltin. The catalyst to be used may be
a palladium catalyst that is generally used in Suzuki-Miyaura
coupling reaction, examples thereof including a palladium
chloride cinnamyl complex, palladium acetate,
trisdibenzylideneacetonedipalladium, and
tetrakistriphenylphenylphosphinopalladium, although the
catalyst is not limited to these. Of these examples, preferred
is tetrakistriphenylphenylphosphinopalladium.
Examples of the base to be used include lithium hydroxide,
sodium hydroxide, potassium hydroxide, sodium carbonate,
potassium carbonate, sodium acetate, potassium acetate, and
further, triethylamine; however, sodium acetate and potassium
acetate are preferred, which are milder.
A preferred solvent to be used is, for example, toluene
or dioxane. The reaction temperature is preferably from room
temperature to 150 C, more preferably from 80 C to 120 C. The
reaction period is preferably from 1 hour to 48 hours, more
preferably from 2 hours to 24 hours.
(Step U-14)
Step U-14 is a step of obtaining a diaryliodonium salt
(615) from the tin compound (614). For the present step, the
following operation is given as an example, although an
operation therefor is not particularly limited.
Production is made by adding an iodonium, such as Koser’s
reagent, to the tin compound (614) under a nitrogen gas flow.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, 2,2,2-trifluoroethanol,
1,1,1,3,3,3-hexafluoroisopropanol, and mixed solvents each
composed of two or more kinds of these solvents. Of these
examples, preferred is dichloromethane,
2,2,2-trifluoroethanol, or
1,1,1,3,3,3-hexafluoroisopropanol.
The reaction temperature is preferably from -20 C to 60 C,
more preferably from -10 C to room temperature. The reaction
period is preferably from 30 minutes to 2 hours.
(Step U-15)
Step U-15 is a step of obtaining a fluorinated compound
(616) from the diaryliodonium salt (615). Examples of the
reagent to be used in Step U-15 include hydrogen fluoride,
potassium fluoride, and cesium fluoride.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, DMF, DMSO, and mixed solvents each composed of two or
more kinds of these solvents. Of these examples, preferred is
dichloromethane alone, acetonitrile alone, DMF alone, DMSO
alone, or a combination of these.
The reaction temperature is preferably from -20 C to 180 C,
more preferably from 80 C to 160 C. The reaction period is
preferably from 5 minutes to 2 hours, more preferably from 10
minutes to 1 hour.
(Step U-16)
Step U-16 is a step of using a pinacol boronation reagent
to produce a pinacol boric acid derivative from the compound
(616) using a microwave radiation in the presence of a palladium
catalyst and a ligand.
The catalyst to be used may be a palladium catalyst that
is generally used in Suzuki-Miyaura coupling reaction, examples
thereof including a palladium chloride cinnamyl complex,
palladium acetate, and trisdibenzylideneacetonedipalladium,
although the catalyst is not limited to these.
The microwave radiation conditions are preferably from
room temperature to 200 C, more preferably from 80 C to 180.
The reaction period is preferably from 1 minute to 60 minutes,
more preferably from 5 minutes to 30 minutes.
The ligand to be used may be a phosphorus-based ligand
that is generally used in Suzuki-Miyaura coupling reaction,
examples thereof including tricyclohexylphosphine,
2-dicyclohexylphosphino-2,4,6-triiso-propylbiphenyl,
2-dicyclohexylphosphino-2,-(N,N)-dimethylaminobiphenyl,
3,5-dimethoxydicyclohexylphosphino-2,4,6-triisopropylbip
henyl, and
3,5-dimethoxyditert-butylphosphino-2,4,6-triisopropylbip
henyl, although the ligand is not limited to these.
Examples of the base to be used include lithium hydroxide,
sodium hydroxide, potassium hydroxide, sodium carbonate,
potassium carbonate, and further, triethylamine, although the
base is not limited thereto. In particular, sodium carbonate
and potassium carbonate are preferred, which are mild.
Preferred examples of the solvent to be used include
toluene, dioxane, and DMDO.
(Step U-17)
Step U-17 is a step of subjecting the compound (615) to
salt exchange reaction for substituting counter-anions, so as
to obtain a compound (618). The reaction reagent may be, for
example, sodium chloride or potassium bromide.
(Step U-18)
Examples of the reagent to be used in Step U-18 include
hydrogen fluoride, potassium fluoride, and cesium fluoride.
Examples of the solvent to be used include water,
dichloromethane, acetone, acetonitrile, THF, methanol,
ethanol, DMF, DMSO, and mixed solvents each composed of two or
more kinds of these solvents. Of these examples, preferred is
dichloromethane alone, acetonitrile alone, DMF alone, DMSO
alone, or a combination of these.
The reaction temperature is preferably from -20C to 180 C,
more preferably from 80 C to 160 C. The reaction period is
preferably from 5 minutes to 2 hours, more preferably from 10
minutes to 1 hour.
(Step U-19)
Step U-19 is a step of using a pinacol boronation reagent
to produce a pinacol boric acid derivative from the compound
(608) in the presence of a palladium catalyst and a ligand. The
catalyst to be used may be a palladium catalyst that is generally
used in Suzuki-Miyaura coupling reaction, examples thereof
including dichlorobis(triphenylphosphine)palladium, a
palladium chloride cinnamyl complex, palladium acetate, and
trisdibenzylideneacetonedipalladium, although the catalyst is
not limited to these.
The ligand to be used may be a phosphorus-based ligand
that is generally used in Suzuki-Miyaura coupling reaction,
examples thereof including tricyclohexylphosphine,
2-dicyclohexylphosphino-2,4,6-triiso-propylbiphenyl,
2-dicyclohexylphosphino-2,-(N,N)-dimethylaminobiphenyl,
3,5-dimethoxydicyclohexylphosphino-2,4,6-triisopropylbip
henyl, and
3,5-dimethoxyditert-butylphosphino-2,4,6-triisopropylbip
henyl, although the ligand is not limited to these.
Examples of the base to be used include sodium acetate,
potassium acetate, lithium hydroxide, sodium carbonate,
potassium carbonate, and further, triethylamine, although the
base is not limited thereto. In particular, sodium acetate and
potassium acetate are preferred, which are mild.
Preferred examples of the solvent to be used include
toluene, dioxane, and DMSO. The reaction temperature is
preferably from room temperature to 150 C, more preferably from
80 C to 120 C.
The reaction period is preferably from 30 minutes to 48
hours, more preferably from 2 hours to 18 hours.
(Step U-20)
Step U-20 is a step of causing the compound (619) to react
with a fluorination reagent in the presence of a copper catalyst
to obtain a compound (616). The fluorination reagent to be used
may be, for example, hydrogen fluoride or potassium fluoride.
Examples of the solvent to be used include toluene,
dioxane, DMF, DMSO, and MeCN, among which DMF and MeCN are
preferred.
The reaction temperature is preferably from room
temperature to 150 C, more preferably from 80 C to 120 C.
The reaction period is preferably from 1 minute to 60
minutes, more preferably from 5 minutes to 30 minutes.
(Step V-1 to Step V-4)
Steps V-1 to V-4 are steps similar to Steps S-2 to S-5
and are steps of preparing compounds 701, 702, 703, 704, and
705.
(Step V-5)
Further, Step V-5 is similar to Step U-11.
When F is contained in the compound in each derivative,
labeling can be carried out with F instead of F.
For example, accelerated protons may be radiated onto
18 18 18
H O to synthesize H F-hydrofluoric acid through O(p, n)
reaction, and then this acid may be passed through an ion
exchange resin column to be adsorbed thereon to separate this
acid from H O which is a non-adsorbed raw material. This
column is subjected to elution with an aqueous solution of K CO
+18 -
to yield K F , which can be used as a nucleophilic agent.
[Formula 16]
When N=N-NR R is present before fluorination among the
compounds in the present invention, labeling with F can be
achieved by a known method. That is, the obtained F anions
are used as a nucleophilic agent, and the anions are heated
together with a phase transfer catalyst in an organic solvent,
thereby yielding a labeled body.
Further, with respect to Sn(R ) , the labeled body is
obtained by a technique of Ermert and others (Non-Patent
Document: J. Label. Compd. Radiopharm., 47, 429, 2004.). In
other words, the labeled body is yielded with a good efficiency
by causing reaction with hydroxyl(tosyloxy)Iodoarene, such as
Koser’s reagent, to produce a diallyliodonium salt temporarily,
and then causing this salt to react with a nucleophilic agent
18 -
Furthermore, each protecting group can be de-protected
by a conventional method, whereby the target fluorinated BPA
can be prepared.
By using the method of the present invention, such
F-labeled compound can be obtained with a comparatively good
yield and in a state having a good specific activity.
EXAMPLES
The present invention will be described in more detail
by way of the following Examples; however, such inventions are
not limited to this alone.
Here, in the Examples described below, the following
machines and reagents were used for analyzing compounds and
isolating/purifying the compounds.
NMR spectrum: JN M-AL series AL400 manufactured by JEOL Ltd.
at 400 MHz
Microwave radiation: Initiator+ manufactured by Biotage
UPLC analysis: ACQUITY UPLC system manufactured by Nihon Waters
K.K.
(Example 1)
Production of 4-bromoiodotoluene
Into 30% sulfuric acid (100 mL), 4-bromoaminotoluene
(10.0 g, 53.7 mmol) was suspended. To this, an aqueous solution
(15 mL) of sodium nitrite (3.89 g, 56.4 mmol) was dropwise added
slowly from a dropping funnel while the system was being cooled
with ice. The resultant was stirred at 0 C for 45 minutes.
Thereafter, sodium iodide (12.1 g, 80.6 mmol) was dissolved into
water (50 mL). To this aqueous solution was added the
above-mentioned diazonium salt solution. The resultant was
stirred further for 1 hour at room temperature, and then was
subjected to extraction with ethyl acetate for 3 times.
Subsequently, the ethyl acetate layer was washed with a
saturated saline solution once, then dried over magnesium
sulfate, and concentrated under a reduced pressure.
Thereafter, the resultant was purified with a silica gel column
(n-hexane) to yield the target compound (9.0 g, 45%).
H-NMR(CDCl ); 2.37(s, 3H, CH ), 7.08(d, J=8.0, 1H, Ar), 7.35(dd,
J=1.6, 8.0, 1H, Ar), 7.93(d, J=2.0, 1H, Ar).
Production of 4-bromoiodobenzyl bromide
To carbon tetrachloride (100 mL) were added
4-bromoiodotoluene (9.00 g, 23.9 mmol) obtained in the
previous step, N-bromosuccinimide (5.95 g, 33.5 mmol), and
2,2-azobis(2-methylpropionitrile) (39 mg, 2.4 mmol) to cause
the reactants to react with each other for 18 hours while the
reaction system was refluxed. Thereafter, the reaction liquid
was filtrated, and the resultant filtrate was concentrated
under a reduced pressure. The resultant was purified through
silica gel column chromatography (n-hexane) to yield 7.0 g of
the target compound (78%).
H-NMR(CDCl ); 4.53(s, 2H, CH ), 7.32(d, J=8.0, 1H, Ar), 7.46(dd,
J=2.0, 8.4, 1H, Ar), 7.93(d, J=2.0, 1H, Ar).
Production of benzyl
3-(4-bromoiodophenyl)(diphenylmethyleneamino)propanoa
To toluene (100 mL) were added cesium hydroxide (7.54 g,
50.3 mmol), benzyl N-(diphenylmethylene)glycinate (5.50 g,
16.7 mmol), and O-allyl-Nanthracenylmethylcinchonidium
bromide (1.10 g, 1.67 mmol, 0.1 equiv). The resultant was
cooled to 0C. Thereafter, while this toluene mixture solution
was being violently stirred, a toluene (10 mL) solution of the
compound (6.30 g, 16.7 mmol) obtained in the previous step was
added all at a time. After the end of dropwise addition, the
resultant was stirred for 18 hours while being kept as it was.
Thereafter, the reaction solution was subjected to extraction
with ether (50 ml) for two times, and further, this ether layer
was washed with a saturated saline solution, then dried over
magnesium sulfate, and concentrated under a reduced pressure,
thereby to yield a crude target compound (8.7 g).
This compound was subjected to the next step without being
purified.
Production of benzyl
2-amino(4-bromoiodophenyl)propanoate
The compound benzyl
3-(4-bromoiodophenyl)(diphenylmethyleneamino)propanoa
te (8.6 g) obtained in the previous step was dissolved into THF
(86 mL), and further, a 30% aqueous solution of citric acid (50
mL) was added thereto. This mixture solution was caused to
undergo a reaction under reflux for 1 hour. After the end of
the reaction, the reaction solution was washed with ether (80
mL), and then neutralized with potassium carbonate.
Thereafter, the resultant was subjected to extraction with
EtOAc (80 mL) for two times, dried over magnesium sulfate, and
then concentrated under a reduced pressure. Further, the
resultant was purified through silica gel column chromatography
(AcOEt / n-hexane =
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013-260451 | 2013-12-17 | ||
JP2013260451 | 2013-12-17 | ||
PCT/JP2014/083243 WO2015093469A1 (en) | 2013-12-17 | 2014-12-16 | Production method for 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ720609A NZ720609A (en) | 2021-11-26 |
NZ720609B2 true NZ720609B2 (en) | 2022-03-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10344042B2 (en) | Production method for 2-fluoro-4-borono-L-phenylalanine, and precursor of 2-fluoro-4-borono-L-phenylalanine | |
US9815855B2 (en) | Method for producing 4-borono-L-phenylalanine having 18F atom introduced thereinto, and precursor of 4-borono-L-phenylalanine having 18F atom introduced thereinto | |
JP6248042B2 (en) | Chiral 4-boronophenylalanine (BPA) derivative and production method, and production method of 18F-labeled BPA using the derivative | |
Takada et al. | Radiosynthesis of [2-11C-carbonyl] dantrolene using [11C] phosgene for PET | |
Kuboyama et al. | Stoichiometry-focused 18F-labeling of alkyne-substituted oligodeoxynucleotides using azido ([18F] fluoromethyl) benzenes by Cu-catalyzed Huisgen reaction | |
WO2020119206A1 (en) | Radioactive iodine-labelled larotrectinib compound, preparation method therefor and use thereof | |
NZ720609B2 (en) | Production method for 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine | |
Roslin et al. | Synthesis and in vitro evaluation of 5-substituted benzovesamicol analogs containing N-substituted amides as potential positron emission tomography tracers for the vesicular acetylcholine transporter | |
Donovan et al. | Preparation and evaluation of reagents for tagging amino and thiol groups with fluorous stannanes. A convenient method for producing radioiodinated compounds in high effective specific activity | |
Liu et al. | Automated synthesis of N‐(2‐[18F] Fluoropropionyl)‐l‐glutamic acid as an amino acid tracer for tumor imaging on a modified [18F] FDG synthesis module | |
KR20210036854A (en) | Practical method for preparation of 2-[18F]fluoro-4-boronophenylalanine | |
CN105324368A (en) | Compound suitable for detection of vesicular acetylcholine transporter |